Akram Al-Ibraheem, Sudqi Allouzi, Ahmed Saad Abdlkadir, Miriam Mikhail-Lette, Kamal Al-Rabi, Mohammad Ma'koseh, Peter Knoll, Zaid Abdelrhman, Omar Shahin, Malik E Juweid, Diana Paez, Egesta Lopci
2-Deoxy-2-[18F]fluoro-d-glucose PET/computed tomography ([18F]FDG PET/CT) has proven to be a sensitive method for the detection and evaluation of hematologic malignancies, especially lymphoma. The increasing incidence and mortality rates of leukemia have raised significant concerns. Through the utilization of whole-body imaging, [18F]FDG PET/CT provides a thorough assessment of the entire bone marrow, complementing the limited insights provided by biopsy samples. In this regard, [18F]FDG PET/CT has the ability to assess diverse types of leukemia The utilization of [18F]FDG PET/CT has been found to be effective in evaluating leukemia spread beyond the bone marrow, tracking disease relapse, identifying Richter's transformation, and assessing the inflammatory activity associated with acute graft versus host disease...
April 22, 2024: Nuclear Medicine Communications